Evolent Health, Inc. (EVH)

Evolent Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-142.26	-19.16	-37.6	-334.25	-301.97
Depreciation & Amortization	123.42	67.2	60.04	61.48	60.91
Share-Based Compensation	40.5	33.98	16.71	14.61	15.62
Other Operating Activities	91.71	-93.57	-0.4	241.94	182.8
Operating Cash Flow	142.58	-11.55	38.75	-16.23	-42.65
Capital Expenditures	-28.75	-38.36	-24.98	-29.47	-35.53
Acquisitions	-387.67	-226.31	-2.53	157.17	-8.58
Change in Investments	0.87	5.55	11.72	133.27	-90.63
Other Investing Activities	-	-	-	0.11	-46.9
Investing Cash Flow	-415.54	-259.12	-15.79	261.07	-181.63
Share Issuance / Repurchase	12.52	4.45	13.29	2.58	1.09
Debt Issued / Paid	181.78	160.29	-37.69	7.41	-41.62
Other Financing Activities	87.04	-33.2	-5.15	-21.85	4.98
Financing Cash Flow	281.34	131.54	-29.55	-11.86	-35.55
Exchange Rate Effect	-0.08	-0.66	-0.05	0.07	0.03
Net Cash Flow	8.3	-139.78	-6.64	233.05	-259.79
Free Cash Flow	113.84	-49.91	13.76	-45.7	-78.18
Free Cash Flow Margin	5.80%	-3.69%	1.52%	-4.94%	-11.38%
Free Cash Flow Per Share	1.02	-0.53	0.16	-0.54	-0.95

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).